First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences

SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences:

Guggenheim 3(rd) Annual Healthcare Innovation Conference, Boston * Format – Fireside chat and one-on-one investor meetings * Date and Time – Tuesday, Nov. 10, 2026 at 11:30am ET Jefferies Global Healthcare Conference, London * Format – Presentation and one-on-one investor meetings * Date and Time – Monday, Nov. 16, 2026 at 4:30pm GMT / 11:30am ET UBS Global Biopharma Conference 2026, London * Format – Fireside chat and one-on-one investor meetings * Date and Time – Tuesday, Nov. 17, 2026 at 11:40am GMT / 6:40am ET Piper Sandler 38(th) Annual Healthcare Conference, New York * Format – Fireside chat and one-on-one investor meetings * Date and Time – Tuesday, Dec. 1, 2026 at 1:30pm ET 9(th) Annual Evercore Healthcare Conference, Miami * Format – Fireside chat and one-on-one investor meetings * Date and Time – Wednesday, Dec. 2, 2026 at 12:30pm ET Live webcasts of the presentation and fireside chats will be available on the investor section of the First Tracks website at https://ir.firsttracksbio.com/news-events/events. Replays of the webcasts will be available for at least 30 days following the events.